AbbVie Partnering with Global Authorities to Determine Efficacy of HIV Drug in Treating COVID-19

AbbVie Statement on Coronavirus and lopinavir/ritonavir

As one of the first pharmaceutical companies to respond to the emerging novel coronavirus (COVID-19) crisis, in late January, AbbVie donated a supply of Kaletra/Aluvia (lopinavir/ritonavir) to the Chinese health authorities for use as an experimental treatment option....